Gemini Therapeutics, Inc. /DE·4

Jan 14, 9:01 AM ET

Piekos Brian 4

4 · Gemini Therapeutics, Inc. /DE · Filed Jan 14, 2022

Insider Transaction Report

Form 4
Period: 2022-01-13
Piekos Brian
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-01-13+280,876280,876 total
    Common Stock (280,876 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
  • [F2]These Restricted Stock Units shall vest on the one (1)-year anniversary of the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION